Infantile seborrhoeic dermatitis / cradle cap

Meet the patient

A 6-week-old, thriving and feeding well, is brought in with a sticky yellow crust over the vertex of the scalp, a salmon-pink greasy patch behind each ear, and a little scale in the eyebrows. The parents have been told it is eczema and given a potent steroid. The baby is unbothered, sleeps and feeds normally, and the crust is the only finding.[6][7]

Hold the two questions that anchor the topic: how itchy is this baby? (cradle cap barely itches; atopic dermatitis does) and is the baby thriving? (a thriving infant with greasy scale is cradle cap; a failing-to-thrive infant with a refractory seborrhoeic-like rash is an immunodeficiency or histiocytosis until proven otherwise).[1][8]

What cradle cap is — the early-life phenotype of seborrhoeic dermatitis

Infantile seborrhoeic dermatitis (ISD) is the early-life phenotype of seborrhoeic dermatitis, presenting classically as cradle cap — greasy yellow scale on the scalp of young infants — with or without involvement of other seborrhoeic and intertriginous sites. It is kin to adult seborrhoeic dermatitis but is typically more self-limited, because infantile sebum production declines after the early months.[3][5][6]

The spectrum runs from mild pityriasiform scalp scale, through classic cradle cap, to an intertriginous or napkin seborrhoeic pattern with fold involvement. Onset is usually within the first 3 months of life, and most infants improve by 6 to 12 months — the natural history examiners expect you to quote.[6][7][8]

The itch splitter — ISD versus atopic versus nappy dermatitis

Itch is the splitter. Cradle cap is greasy, yellow, scalp-and-face, and barely itches; the baby is comfortable. Infantile atopic dermatitis is dry, eczematous, facial and extensor, and itches enough to disrupt sleep. Irritant nappy dermatitis is a glazed erythema of the convex surfaces that spares the folds — whereas the seborrhoeic and candidal napkin pattern involves the folds.[6][8]

[1]

The classic trap: labelling an itchy, dry, sleep-disrupting facial rash as "cradle cap" and under-treating the itch — that is infantile atopic dermatitis, and it wants emollients and an anti-inflammatory plan, not shampoo. Reclassify when itch dominates.[6][8]

Why it happens — androgen-driven sebum meets Malassezia

Infantile sebum production is driven by maternal androgens and the early postnatal endocrine milieu, creating a lipid-rich habitat for Malassezia yeasts. Yeast lipase activity and the host inflammatory response to fungal products and free fatty acids generate the erythema with greasy scale on scalp and flexures. As sebaceous activity falls later in infancy, the ecological drive wanes and the disease remits — the mechanistic reason cradle cap is self-limited.[5][10]

Etymology for viva gold: seborrhoeic is from the Latin sebum, tallow, and Greek rhoia, flow — the "flow of tallow" that paints the greasy scale. The name predates the yeast by a century but describes the substrate exactly.[5]

How common — and who

ISD is one of the common rashes of early infancy. A global seborrhoeic dermatitis meta-analysis shows meaningful population prevalence across ages, with lower rates in neonates than older groups overall; in clinical practice cradle cap is a familiar sight in the first weeks of life.[9] Risk factors are the ones that feed the fold-and-sebum environment: a family history of seborrhoeic or atopic disease, occlusive clothing, and warm humid climate. Infants are typically systemically well, which is itself a diagnostic clue.[6][8]

Clinical presentation

• Scalp: thick, greasy, yellow, adherent scale on a salmon-pink base; vertex and anterior scalp common.[6][7]
• Face: eyebrows, glabella, nasolabial folds, retroauricular creases.
• Body: neck folds, axillae, inguinal and napkin folds involved — the contrast with irritant nappy dermatitis, which spares them.
• Itch minimal or absent — the infant is usually comfortable relative to atopic dermatitis.
• Feeding, growth and behaviour are typically normal.[6][8]

The Cochrane truth — surprisingly thin evidence for actives

A consultant confession worth carrying into the viva: the 2019 Cochrane review found limited high-quality evidence for any specific active intervention in infantile seborrhoeic dermatitis. Counselling and gentle care remain foundational; treat inflammation or yeast when clinically needed, but do not overstate the certainty of any one active. The JAAD Cochrane summary reinforces the same point.[1][2]

This evidence humility is itself examinable: a candidate who reaches straight for a potent steroid betrays that they have not read the Cochrane review. Gentle scale care first, cautious actives second, red-flag vigilance always.[1]

Management — the ladder

The practical ladder used internationally is deliberately gentle, because the disease is self-limited and the evidence for actives is thin:[1]

[1]

Medicated topicals — cautious, short, low-potency

• Short course of a low-potency topical corticosteroid (the hydrocortisone class) for inflamed scalp or skin when scale care alone is insufficient.[3][4]
• Topical imidazole antifungals (clotrimazole or ketoconazole cream) when yeast-driven or persistent intertriginous disease is suspected.[3][4]
• Avoid prolonged potent steroids on the infant scalp or face — atrophy and hypothalamic-pituitary-adrenal-axis suppression are real risks on infant skin.[3]
• Adult innovations such as roflumilast foam are not the standard cradle-cap pathway for young infants.[4]

Everyone forgets: a topical agent on an infant's scalp or face is absorbed far more than on an adult's, because the barrier is thinner and the surface-to-weight ratio higher. Low potency, short course, limited area — every time.[3]

Bedside assessment and investigations

Diagnosis is clinical in the typical well infant. Examine all seborrhoeic sites, plot the growth chart, and take an infection history. Investigations are selective: a swab if superinfection is suspected, and a broader work-up — immunology, skin biopsy — only if the red flags for immunodeficiency or Langerhans cell histiocytosis appear.[3][6][7][8]

When cradle cap is not cradle cap — the red flags

[5] [8]

A severe, widespread, refractory seborrhoeic-like dermatitis in a failing-to-thrive infant is the classic presentation that should never be dismissed as "stubborn cradle cap". The broader differential of severe infantile dermatitis includes entities such as leucocyte adhesion deficiency; the point is to escalate, not to keep shampooing.[5][8]

Complications and pitfalls

Secondary bacterial or candidal infection can supervene on broken skin. Steroid misuse by caregivers — sharing a potent steroid meant for an adult — is the commonest iatrogenic problem. Misdiagnosing atopic dermatitis as cradle cap under-treats the itch, while mislabelling Langerhans cell histiocytosis as stubborn cradle cap delays a biopsy. Parental distress is often out of proportion to the medical risk — address it with a clear, honest prognosis.[1]

Prognosis and follow-up

Most infants improve within the first year, and infantile disease does not reliably predict adult seborrhoeic dermatitis. Re-review if the rash is not improving, if itch escalates (think atopic dermatitis), or if any red flag appears. Cradle cap that behaves like cradle cap will resolve; cradle cap that does not is something else.[6]

The evidence, and where practice converges

Exam anchors are the Cochrane ISD review,[1] the JAAD Cochrane summary,[2] the AFP diagnosis and treatment overviews,[3][7] the comprehensive treatment review,[4] the classic JEADV SD review,[5] the cradle cap clinical reviews,[6][8] the global prevalence meta-analysis,[9] and the Malassezia biology update.[10] UK, ANZ and Indian practice converge on the same sequence: gentle scale care first, medicated topicals second, systemic therapy almost never for uncomplicated cradle cap.[1]

The mnemonic, and the mantra

[1]

The mantra: greasy and unbothered is cradle cap; dry and itchy is atopic; failing to thrive is something else entirely.[1][6]

Ward-round test — three stems, thirty seconds each

Stem 1 — the 6-week-old with a yellow crust (answer)

A thriving 6-week-old has greasy yellow adherent scale over the vertex and behind the ears, minimal itch, and normal feeding. What is the diagnosis, and what is the first step? Model: This is classic infantile seborrhoeic dermatitis (cradle cap) — greasy yellow scale on sebum-rich sites in a thriving, unbothered infant. The first step is reassurance and gentle scale care: soften with an emollient or oil, leave it on, then gently comb out — never force or scrape — plus a mild shampoo. The condition is self-limited, usually resolving within months. No potent steroid; no investigation unless red flags appear.[1][6]

Stem 2 — the itchy cheeks and sleepless nights (answer)

A 4-month-old has dry, eczematous cheeks and extensor patches, scratches at them, and wakes at night. The parents call it cradle cap. What is the actual diagnosis, and why does the label matter? Model: This is infantile atopic dermatitis, not cradle cap — the discriminating feature is itch with sleep loss and a dry eczematous morphology on cheeks and extensors. The label matters because the management differs: atopic dermatitis wants emollients and an anti-inflammatory plan guided by atopic principles, plus attention to triggers and family atopy, not the scale-softening and shampoo pathway of cradle cap. The itch is the splitter.[6][8]

Stem 3 — the seborrhoeic rash that will not settle (answer)

A 5-month-old has a severe, widespread, refractory seborrhoeic-like dermatitis, chronic diarrhoea, recurrent infections, and is failing to thrive. What must you not do, and what is the right pathway? Model: Do not keep shampooing or escalating topical steroids. Severe refractory seborrhoeic-like dermatitis with failure to thrive, diarrhoea, and recurrent infections is a red flag for immunodeficiency (and the differential of severe infantile dermatitis includes entities such as leucocyte adhesion deficiency). The right pathway is an immunology and paediatric work-up, with a skin biopsy if Langerhans cell histiocytosis is also in the frame. "Stubborn cradle cap" is a misdiagnosis that costs time.[5][8]

References

1. [1]Victoire A, Magin P, Coughlan J, et al. Interventions for infantile seborrhoeic dermatitis (including cradle cap) Cochrane Database Syst Rev, 2019.PMID 30828791
2. [2]Hassan S, Szeto MD, Sivesind TE, et al. From the Cochrane Library: Interventions for infantile seborrheic dermatitis (including cradle cap) J Am Acad Dermatol, 2022.PMID 34571061
3. [3]Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis Am Fam Physician, 2015.PMID 25822272
4. [4]Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review J Dermatolog Treat, 2019.PMID 29737895
5. [5]Gupta AK, Bluhm R. Seborrheic dermatitis J Eur Acad Dermatol Venereol, 2004.PMID 14678527
6. [6]Nobles T, Harberger S, Krishnamurthy K. Cradle Cap(Archived) 2026.PMID 30285358
7. [7]O'Connor NR, McLaughlin MR, Ham P. Newborn skin: Part I. Common rashes Am Fam Physician, 2008.PMID 18236822
8. [8]Chadha A, Jahnke M. Common Neonatal Rashes Pediatr Ann, 2019.PMID 30653638
9. [9]Polaskey MT, Chang CH, Daftary K, et al. The Global Prevalence of Seborrheic Dermatitis: A Systematic Review and Meta-Analysis JAMA Dermatol, 2024.PMID 38958996
10. [10]Adalsteinsson JA, Kaushik S, Muzumdar S, et al. An update on the microbiology, immunology and genetics of seborrheic dermatitis Exp Dermatol, 2020.PMID 32125725